Saint Kitts and Nevis vs Tajikistan: Immunization, Hib3
Saint Kitts and Nevis
97.0%
in 2024
Tajikistan
97.0%
in 2024
Saint Kitts and Nevis rank
29th
Tajikistan rank
29th
Immunization, Hib3 over time
- Saint Kitts and Nevis
- Tajikistan
How they compare
Saint Kitts and Nevis currently reports 97.0% against 97.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2008 it was Saint Kitts and Nevis ahead.
Saint Kitts and Nevis ranks 29th and Tajikistan ranks 29th of 191 countries.
Saint Kitts and Nevis has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 69.5% | 27.5% | Saint Kitts and Nevis |
| 2010s | 97.2% | 95.9% | 1.3% | Saint Kitts and Nevis |
| 2020s | 96.8% | 96.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Saint Kitts and Nevis or Tajikistan?
- Saint Kitts and Nevis, at 97.0% against 97.0% in Tajikistan as of 2024.
- What is the difference in immunization, hib3 between Saint Kitts and Nevis and Tajikistan?
- 0.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Tajikistan?
- 17 years are reported by both, from 2008 to 2024.
- How do Saint Kitts and Nevis and Tajikistan rank globally for immunization, hib3?
- Saint Kitts and Nevis ranks 29th and Tajikistan ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.